Management of gestational trophoblastic neoplasia with vaginal metastasis Vajinal metastazı olan gestasyonel trofoblastik neoplazinin yönetimi
Marmara Medical Journal, cilt.26, sa.1, 2013 (Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 26 Sayı: 1
- Basım Tarihi: 2013
- Doi Numarası: 10.5472/mmj.2012.02581.1
- Dergi Adı: Marmara Medical Journal
- Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
- Anahtar Kelimeler: Gestational trophoblastic neoplasia, Vaginal metastasis, Methotrexate, Actinoycin-D
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
A patient who had gestational trophoblastic neoplasia (GTN) with vaginal metastasis resistant to sequential methotrexatefolinic acid (MTX-FA) treatment is presented. She was 25 years old and presented with vaginal bleeding. A curettage was performed and the pathology revealed a partial hydatidiform mole. There was a rise in β-hCG, a 2 cm metastatic lesion on the middle third of the right wall of the vagina, and there were nodular implants up to a size of 12 mm in both lungs. Therefore, she was diagnosed as having a GTN. She was considered as having low risk metastatic GTN, as her modified WHO score was 3. She took seven cycles of sequential MTX-FA theraphy. She was accepted as resistant to MTX-FA and her treatment was changed to actinoycin-D, because her β-hCG values plateaued. Her β-hCG was normalized after the second cycleof actinoycin-D. She took 2 additional cycles of actinoycin-D. Resistance to MTXFA may develop in patients who had a GTN with vaginal metastasis, even though they have low risk scores. These patients may respond to actinoycin-D.